Health and Fitness Health and Fitness
Mon, September 27, 2010
[ Mon, Sep 27th 2010 ] - Market Wire
Wellstar Announces New Website
Sun, September 26, 2010
Sat, September 25, 2010
Fri, September 24, 2010
Thu, September 23, 2010
Wed, September 22, 2010
Tue, September 21, 2010
Mon, September 20, 2010
Fri, September 17, 2010
Thu, September 16, 2010
Wed, September 15, 2010
[ Wed, Sep 15th 2010 ] - Market Wire
Qtrax Beta Available in India
Tue, September 14, 2010
Mon, September 13, 2010
Sun, September 12, 2010
Fri, September 10, 2010
Thu, September 9, 2010
Wed, September 8, 2010
Tue, September 7, 2010
Sat, September 4, 2010
[ Sat, Sep 04th 2010 ] - Market Wire
Transdel Pharmaceuticals
Fri, September 3, 2010
[ Fri, Sep 03rd 2010 ] - Market Wire
Transdel Pharmaceuticals

Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of ZymoGenetics, Inc.


//health-fitness.news-articles.net/content/2010/ .. -behalf-of-shareholders-of-zymogenetics-inc.html
Published in Health and Fitness on Tuesday, September 14th 2010 at 17:40 GMT by Market Wire   Print publication without navigation


BENSALEM, Pa.--([ BUSINESS WIRE ])--Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of ZymoGenetics, Inc. (aZymoGeneticsa or the aCompanya) (NASDAQ:ZGEN) related to the Companya™s agreement to be acquired by Bristol-Myers Squibb Company (aBristol-Myersa). The proposed transaction is valued at approximately $885 million.

Under the terms of the definitive agreement entered into by the parties, a wholly owned subsidiary of Bristol-Myers has commenced a cash tender offer to purchase all of the outstanding shares of ZymoGenetics common stock for $9.75 per share. Shareholders holding approximately 37% of the outstanding shares of ZymoGenetics common stock have entered into agreements with Bristol-Myers to tender their shares in the offer. In addition, the merger agreement includes a provision under which ZymoGenetics has agreed not to solicit any competing offers for the Company. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by ZymoGeneticsa™ board of directors.

If you own shares of ZymoGenetics, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to [ howardsmith@howardsmithlaw.com ], or visit our website at [ http://www.howardsmithlaw.com ].


Publication Contributing Sources